Fig. 1From: Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccineTrial profile. Volunteers meeting the eligibility criteria were enrolled in one of four GAP vaccine dose cohorts. Dose escalation was performed in cohorts 1 to 3; cohort 4 received the same dose as cohort 3Back to article page